This article explores the limitations of SPOS, and provides an overview of chemoenzymatic ligation, its mechanism, and comparative advantages in siRNA and sgRNA synthesis.
We offer a comprehensive range of products and services to support customers throughout the entire RNA medicine development process, from initial design to commercial manufacturing.
Mar 18, 2025David Butler
This article explores the limitations of SPOS, and provides an overview of chemoenzymatic ligation, its mechanism, and comparative advantages in siRNA and sgRNA synthesis.